Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02291458Phase 3Unknown
Phase 3, randomised trial of arginine in glucose intolerance and obesity (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Standard uptake value of Brown adipose tissue at 6 weeks, Energy expenditure at 6 weeks and 1 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02291458.